GO:0034693 U11/U12 snRNP: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0034693 describes the U11/U12 snRNP, a ribonucleoprotein complex formed by the association of the U11 and U12 small nuclear ribonucleoproteins.
• The human 18S U11/U12 snRNP contains a set of novel proteins not found in the U2-dependent spliceosome, including U11-59K, U11-48K, and U11/U12-65K.
• The U11/U12-65K protein acts as a molecular bridge, binding both U12 snRNA and the U11-59K protein, thereby stabilizing the di-snRNP complex.
• The U11/U12 snRNP is a core component of the minor spliceosome, which catalyzes the removal of U12-type introns from pre-mRNA.
• Evolutionarily conserved exon definition interactions with U11 snRNP mediate alternative splicing regulation on U11-48K and U11/U12-65K genes.
• Dysregulation of minor spliceosome components, including U11/U12 snRNP proteins, has been linked to cancer and other human diseases.
Description
The U11/U12 snRNP (GO:0034693) is a cellular component defined as a ribonucleoprotein complex formed by the association of the U11 and U12 small nuclear ribonucleoproteins. This complex is a hallmark of the minor spliceosome, a low-abundance splicing machinery that recognizes and removes U12-type introns from pre-mRNA. Unlike the major U2-dependent spliceosome, the minor spliceosome contains U11 and U12 snRNPs, which interact to form a two-snRNP complex essential for the splicing of a subset of introns. The human 18S U11/U12 snRNP is characterized by a set of novel proteins not found in the U2-dependent spliceosome, underscoring its unique structural and functional identity. Researchers study the U11/U12 snRNP because it plays a critical role in gene expression and its dysfunction is increasingly implicated in human disease. The complex is required for the correct processing of U12-type introns, which are present in a significant number of human genes. Mutations or altered expression of U11/U12 snRNP components can disrupt splicing and contribute to cancer, developmental disorders, and other pathologies. Understanding the assembly, structure, and regulation of this complex is therefore essential for both basic biology and translational research. This article provides a comprehensive overview of the U11/U12 snRNP, covering its definition, composition, molecular mechanisms, associated genes, disease links, and the experimental methods used to study it. By integrating authoritative QuickGO data with verified PubMed literature, we aim to support researchers in designing robust experiments and interpreting their findings in the context of minor spliceosome biology.
U11/U12 snRNP At A Glance
| GO ID | GO:0034693 |
|---|---|
| GO term | U11/U12 snRNP |
| Ontology | cellular_component |
| Synonym | 18S U11/U12 snRNP, snRNP U11/U12 |
| Major function | Formation of a di-snRNP complex essential for minor spliceosome assembly and U12-type intron splicing |
| Composition | Contains U11 and U12 snRNAs and novel proteins such as U11-59K, U11-48K, and U11/U12-65K |
| Assembly | U11 and U12 snRNPs interact to form a two-snRNP complex; U11/U12-65K bridges U12 snRNA and U11-59K |
| Related complex | Minor spliceosome (U12-dependent spliceosome) |
| Evolutionary conservation | Components and interactions are evolutionarily conserved |
What Is GO:0034693?
The U11/U12 snRNP is a ribonucleoprotein complex that forms when the U11 and U12 small nuclear ribonucleoproteins associate with each other. It is also known as the 18S U11/U12 snRNP or snRNP U11/U12. This complex is a key building block of the minor spliceosome and is required for the recognition and splicing of U12-type introns.
Why Is U11/U12 snRNP Important in Cell Biology?
The U11/U12 snRNP is essential for the minor spliceosome, a low-abundance but critical splicing machinery that processes U12-type introns in a subset of human genes. Proper function of this complex ensures accurate pre-mRNA splicing, and its dysregulation has been linked to cancer and other diseases. Studying the U11/U12 snRNP provides insights into fundamental RNA processing mechanisms and offers potential therapeutic targets for splicing-related disorders.
• Required for the splicing of U12-type introns, which are present in many human genes.
• Contains unique proteins not found in the major spliceosome, making it a distinct research target.
• The U11/U12-65K protein acts as a molecular bridge, stabilizing the di-snRNP complex.
• Evolutionarily conserved interactions with U11 snRNP regulate alternative splicing of its own components.
• Dysregulation of minor spliceosome components is implicated in cancer and other human diseases.
• Mutations in U11/U12 snRNP components can abolish splicing regulation, as shown for RSV intronic elements.
• The complex undergoes major conformational changes upon integration into the spliceosome, affecting function.
• Studying U11/U12 snRNP helps understand tissue-specific and developmentally regulated splicing.
• It is a potential target for therapeutic intervention in diseases caused by splicing defects.
• Provides a model for understanding the evolution of spliceosomal complexes.
U11/U12 snRNP: Biological Process, Cellular Component, and Molecular Function
What Happens During U11/U12 snRNP Assembly?
In simple terms: The U11 and U12 snRNPs come together to form a stable pair, which is the first step in building the minor spliceosome.
The U11/U12 snRNP is formed by the association of the U11 and U12 small nuclear ribonucleoproteins. This interaction creates a two-snRNP complex that is essential for the minor spliceosome. The human 18S U11/U12 snRNP contains a set of novel proteins not found in the U2-dependent spliceosome, including U11-59K, U11-48K, and U11/U12-65K. The U11/U12-65K protein acts as a molecular bridge, binding the U12 snRNA and the U11-59K protein, thereby stabilizing the complex. This assembly is a prerequisite for the subsequent steps of minor spliceosome function.
Role in Minor Spliceosome Function
In simple terms: Once formed, the U11/U12 snRNP helps the minor spliceosome recognize and cut out U12-type introns from pre-mRNA.
The U11/U12 snRNP is a core component of the minor spliceosome, which catalyzes the removal of U12-type introns. The complex participates in the recognition of the 5' splice site and branch point of U12-type introns. Structural studies have revealed that the complex undergoes a major conformational change upon integration into the spliceosomal U11/U12 di-snRNP, as shown by electron cryomicroscopy. This dynamic behavior is critical for the correct positioning of catalytic elements and for splicing fidelity.
Structure and Composition of U11/U12 snRNP
In simple terms: The U11/U12 snRNP is made of two RNA molecules (U11 and U12) and a set of specialized proteins that hold it together and help it work.
The human 18S U11/U12 snRNP contains U11 and U12 snRNAs along with novel proteins such as U11-59K, U11-48K, and U11/U12-65K. The U11/U12-65K protein bridges U12 snRNA and U11-59K, forming a stable interaction network. The complex also includes proteins that are shared with the major spliceosome, but its unique components define its specific functions. The structure of the activated human minor spliceosome has been resolved, providing detailed insights into the arrangement of these components.
Molecular Mechanism of U11/U12 snRNP
In simple terms: The U11/U12 snRNP works by binding to specific sequences in pre-mRNA and helping to catalyze the splicing reaction.
The U11/U12 snRNP binds to U12-type introns through base-pairing interactions between the snRNAs and the pre-mRNA. The U11/U12-65K protein acts as a molecular bridge, facilitating the binding of U12 snRNA to U11-59K and stabilizing the complex. Evolutionarily conserved exon definition interactions with U11 snRNP mediate alternative splicing regulation on U11-48K and U11/U12-65K genes. Mutation of an RSV intronic element abolishes both U11/U12 snRNP binding and negative regulation of splicing, demonstrating the sequence-specific nature of the interaction. These molecular interactions ensure precise splice site selection and catalytic activation.
Regulation of U11/U12 snRNP Components
In simple terms: The amounts and activities of U11/U12 snRNP proteins can be adjusted by the cell, often through alternative splicing of their own mRNAs.
The expression of U11/U12 snRNP components is regulated at multiple levels. Evolutionarily conserved exon definition interactions with U11 snRNP mediate alternative splicing regulation on U11-48K and U11/U12-65K genes, creating a feedback loop that controls the levels of these proteins. Distinct functions for the paralogous RBM41 and U11/U12-65K proteins in the minor spliceosome have been described, suggesting specialized roles in regulation. This regulation ensures that the minor spliceosome is assembled only when needed and in appropriate amounts.
Key Genes Involved in GO:0034693 U11/U12 snRNP
The following genes encode the major protein and RNA components of the U11/U12 snRNP and are central to its function and regulation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| U11-59K (also known as SNRNP35 or U11-59K) | Binds U12 snRNA and interacts with U11/U12-65K to stabilize the complex | Key structural component; target for knockout and knockdown studies |
| U11-48K (also known as SNRNP48 or U11-48K) | Part of the U11 snRNP; involved in exon definition interactions | Regulated by alternative splicing; model for studying feedback regulation |
| U11/U12-65K (also known as RNPC3 or U11/U12-65K) | Acts as a molecular bridge between U12 snRNA and U11-59K | Essential for complex stability; mutations linked to disease |
| RBM41 | Paralogous to U11/U12-65K; distinct functions in minor spliceosome | Emerging target for understanding paralog specialization |
| U11 snRNA | RNA component of U11 snRNP; base-pairs with pre-mRNA | Core RNA; studied via mutagenesis and structural probing |
| U12 snRNA | RNA component of U12 snRNP; binds U11/U12-65K | Core RNA; essential for minor spliceosome catalysis |
| SF3b complex | Integrates into U11/U12 di-snRNP; undergoes conformational change | Studied by cryo-EM to understand spliceosome dynamics |
| PRPF8 | Component of the minor spliceosome; interacts with U11/U12 snRNP | Large scaffold protein; target for structural studies |
| SNRNP200 | RNA helicase involved in spliceosome activation | Regulates conformational changes during splicing |
| U2AF1 | Splicing factor that may interact with minor spliceosome | Potential cross-talk between major and minor spliceosomes |
| ZRSR2 | Minor spliceosome component; frequently mutated in cancer | Cancer biomarker and therapeutic target |
| RNPC3 | Encodes U11/U12-65K; mutations cause developmental disorders | Disease modeling via CRISPR knockout |
| SNRNP35 | Encodes U11-59K; essential for U11/U12 snRNP assembly | Target for functional studies |
| SNRNP48 | Encodes U11-48K; regulated by alternative splicing | Model for splicing autoregulation |
| RBM41 | Paralog of U11/U12-65K; distinct roles in splicing | Comparative knockout studies |
| U11/U12-65K | Bridge protein; binds U12 snRNA and U11-59K | Central to complex integrity; disease relevance |
| U11-59K | Binds U12 snRNA and U11/U12-65K | Structural core; knockout leads to complex destabilization |
| U11-48K | Part of U11 snRNP; mediates exon definition | Regulatory node; alternative splicing target |
How Is U11/U12 snRNP Regulated?
The U11/U12 snRNP is regulated through alternative splicing of its own component mRNAs. Evolutionarily conserved exon definition interactions with U11 snRNP mediate alternative splicing regulation on U11-48K and U11/U12-65K genes, creating a feedback mechanism that controls protein levels. Additionally, distinct functions for the paralogous RBM41 and U11/U12-65K proteins suggest that paralog switching may regulate minor spliceosome activity in different cellular contexts.
U11/U12 snRNP and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| RNPC3 (U11/U12-65K) | Developmental disorders, splicing defects | Knockout or point-mutation cell models to study splicing |
| ZRSR2 | Myelodysplastic syndromes, cancer | Knockout in hematopoietic cell lines; xenograft models |
| SNRNP35 (U11-59K) | Splicing-related diseases | Knockdown and rescue experiments in cell culture |
| SNRNP48 (U11-48K) | Alternative splicing regulation | Minigene reporter assays with CRISPR knockout |
| RBM41 | Minor spliceosome dysfunction | Paralog-specific knockout and overexpression models |
Cancer
Dysregulation of minor spliceosome components, including U11/U12 snRNP proteins, has been implicated in cancer. Mutations in ZRSR2, a minor spliceosome component, are frequently observed in myelodysplastic syndromes and other cancers. Altered expression of U11/U12 snRNP proteins may contribute to aberrant splicing of genes involved in cell proliferation and survival.
Developmental Disorders
Mutations in RNPC3, which encodes the U11/U12-65K protein, have been linked to developmental disorders. The U11/U12-65K protein acts as a molecular bridge essential for minor spliceosome function, and its disruption can lead to splicing defects that affect development.
Splicing-Related Diseases
The U11/U12 snRNP is required for the splicing of U12-type introns, and its dysfunction can cause a range of splicing-related diseases. Mutation of an RSV intronic element abolishes both U11/U12 snRNP binding and negative regulation of splicing, demonstrating how disruption of this complex can lead to aberrant splicing. Understanding these mechanisms may reveal therapeutic targets for diseases caused by splicing defects.
From U11/U12 snRNP-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of U11/U12-65K loss on minor spliceosome assembly? | CRISPR knockout of RNPC3 in HeLa or HEK293 cells |
| How do point mutations in U11-59K affect U12 snRNA binding? | Point-mutation knock-in via CRISPR in cell lines |
| Can tagged U11/U12-65K rescue splicing defects? | Knock-in of epitope-tagged RNPC3 |
| What are the downstream targets of U11/U12 snRNP regulation? | Overexpression of U11/U12-65K followed by RNA-seq |
| How does RBM41 compensate for U11/U12-65K loss? | Double knockout of RNPC3 and RBM41 |
| What is the role of U11/U12 snRNP in cancer cell proliferation? | CRISPR library screening in cancer cell lines |
How to Study the U11/U12 snRNP Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA immunoprecipitation (RIP) | RNA binding sites of U11/U12 snRNP proteins | Mapping target introns and regulatory elements |
| Cryo-electron microscopy | Three-dimensional structure of the minor spliceosome | Understanding conformational changes and assembly |
| Minigene splicing assay | Splicing efficiency of U12-type introns | Functional validation of mutations |
| CRISPR knockout | Loss-of-function phenotypes | Studying essentiality of U11/U12 snRNP components |
| CRISPR knock-in | Effects of specific mutations or tags | Modeling disease-associated point mutations |
| RNA-seq | Global changes in gene expression and splicing | Identifying downstream targets of U11/U12 snRNP |
| Proteomics | Protein composition of the U11/U12 snRNP | Identifying novel components and interactors |
| Electron microscopy | Overall shape and conformational states | Visualizing spliceosome dynamics |
RNA Immunoprecipitation (RIP)
RIP can be used to identify RNAs bound by U11/U12 snRNP proteins. By immunoprecipitating U11/U12-65K or U11-59K and sequencing associated RNAs, researchers can map binding sites and understand target specificity.
Cryo-Electron Microscopy (Cryo-EM)
Cryo-EM has been used to determine the structure of the activated human minor spliceosome, revealing major conformational changes in the complex SF3b upon integration into the U11/U12 di-snRNP. This method provides high-resolution insights into assembly and function.
Minigene Splicing Assays
Minigene reporters containing U12-type introns can be used to measure splicing efficiency in cells with altered U11/U12 snRNP components. This approach helps link molecular changes to splicing outcomes.
CRISPR-Based Knockout and Knock-in
CRISPR/Cas9 technology enables the generation of knockout cell lines for genes encoding U11/U12 snRNP components, as well as knock-in of point mutations or tags. These models are essential for studying gene function and disease-associated mutations.
How CRISPR Can Be Used to Study GO:0034693 U11/U12 snRNP
Knockout
CRISPR knockout of genes encoding U11/U12 snRNP components, such as RNPC3 or SNRNP35, can reveal their essential roles in minor spliceosome assembly and cell viability. These models are useful for identifying downstream splicing defects and compensatory mechanisms.
Point Mutation
Point mutations in U11/U12 snRNP genes can be introduced via CRISPR knock-in to model disease-associated variants. For example, mutations in RNPC3 that disrupt the bridge function of U11/U12-65K can be studied for their impact on splicing.
Knock-in
Knock-in of epitope tags or fluorescent proteins into endogenous U11/U12 snRNP genes allows for live-cell imaging and biochemical purification. This approach helps track complex assembly and localization in real time.
Overexpression
Overexpression of U11/U12 snRNP components can be used to study gain-of-function effects and to rescue knockout phenotypes. It also helps identify dominant-negative mutants and their effects on splicing.
How EDITGENE Supports U11/U12 snRNP Research
Researchers studying U11/U12 snRNP-related genes often need to determine whether a candidate gene is causally involved in minor spliceosome function, splicing regulation, or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research, from gene knockout to precise point mutations and library screening.
Contact EDITGENE today to design your custom CRISPR model for U11/U12 snRNP research.
Frequently Asked Questions About U11/U12 snRNP
What is the U11/U12 snRNP?
The U11/U12 snRNP is a ribonucleoprotein complex formed by the association of the U11 and U12 small nuclear ribonucleoproteins. It is a core component of the minor spliceosome and is required for the splicing of U12-type introns.
What genes are involved in the U11/U12 snRNP?
Key genes include RNPC3 (U11/U12-65K), SNRNP35 (U11-59K), SNRNP48 (U11-48K), and RBM41, as well as the U11 and U12 snRNA genes.
What is the function of the U11/U12-65K protein?
U11/U12-65K acts as a molecular bridge, binding the U12 snRNA and the U11-59K protein to stabilize the U11/U12 snRNP complex.
How is the U11/U12 snRNP assembled?
The U11 and U12 snRNPs interact to form a two-snRNP complex. The U11/U12-65K protein bridges U12 snRNA and U11-59K, facilitating stable assembly.
What diseases are associated with U11/U12 snRNP dysfunction?
Dysregulation of minor spliceosome components, including U11/U12 snRNP proteins, has been linked to cancer, developmental disorders, and splicing-related diseases.
What is the minor spliceosome?
The minor spliceosome is a low-abundance splicing machinery that removes U12-type introns from pre-mRNA. The U11/U12 snRNP is a core component of this complex.
How can I study the U11/U12 snRNP in the lab?
Common methods include RNA immunoprecipitation, cryo-electron microscopy, minigene splicing assays, and CRISPR-based knockout or knock-in models.
What is the role of U11/U12 snRNP in alternative splicing?
Evolutionarily conserved exon definition interactions with U11 snRNP mediate alternative splicing regulation on U11-48K and U11/U12-65K genes, creating a feedback loop.
Are there CRISPR models for U11/U12 snRNP research?
Yes, CRISPR knockout and knock-in models for genes like RNPC3 and SNRNP35 are available and can be custom-generated by EDITGENE.
What is the GO ID for U11/U12 snRNP?
The Gene Ontology ID for U11/U12 snRNP is GO:0034693, under the cellular_component ontology.
Conclusion
The U11/U12 snRNP (GO:0034693) is a specialized ribonucleoprotein complex essential for minor spliceosome function and U12-type intron splicing. Its unique protein components, such as U11/U12-65K, U11-59K, and U11-48K, mediate critical interactions that ensure splicing fidelity. Dysregulation of this complex is increasingly linked to cancer and developmental disorders, making it a compelling target for both basic and translational research. Advances in CRISPR-based models, structural biology, and bioinformatics are accelerating our understanding of the U11/U12 snRNP. EDITGENE provides comprehensive services to support researchers in generating knockout, point-mutation, knock-in, and overexpression models, as well as library screening and bioinformatics analysis, empowering discoveries in minor spliceosome biology and disease.
References
- 1. Will CL et al.. 2004. The human 18S U11/U12 snRNP contains a set of novel proteins not found in the U2-dependent spliceosome.. RNA 10(6):929-41 PMID: 15146077
- 2. Wassarman KM et al.. 1992. The low-abundance U11 and U12 small nuclear ribonucleoproteins (snRNPs) interact to form a two-snRNP complex.. Mol Cell Biol 12(3):1276-85 PMID: 1372090
- 3. Benecke H et al.. 2005. The U11/U12 snRNP 65K protein acts as a molecular bridge, binding the U12 snRNA and U11-59K protein.. EMBO J 24(17):3057-69 PMID: 16096647
- 4. Niemelä EH et al.. 2015. Evolutionarily conserved exon definition interactions with U11 snRNP mediate alternative splicing regulation on U11-48K and U11/U12-65K genes.. RNA Biol 12(11):1256-64 PMID: 26479860
- 5. Golas MM et al.. 2005. Major conformational change in the complex SF3b upon integration into the spliceosomal U11/U12 di-snRNP as revealed by electron cryomicroscopy.. Mol Cell 17(6):869-83 PMID: 15780942
- 6. Bai R et al.. 2021. Structure of the activated human minor spliceosome.. Science 371(6535) PMID: 33509932
- 7. Norppa AJ et al.. 2024. Distinct functions for the paralogous RBM41 and U11/U12-65K proteins in the minor spliceosome.. Nucleic Acids Res 52(7):4037-4052 PMID: 38499487
- 8. Gontarek RR et al.. 1993. Mutation of an RSV intronic element abolishes both U11/U12 snRNP binding and negative regulation of splicing.. Genes Dev 7(10):1926-36 PMID: 8405999
